These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1535508)

  • 21. Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.
    Sessa C; Kaye SB; Renard J; ten Bokkel Huinink W; Cavalli F
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):751-2. PubMed ID: 2523809
    [No Abstract]   [Full Text] [Related]  

  • 22. Menogaril in the treatment of malignant mesothelioma: a phase II study.
    Hudis CA; Kelsen DP
    Invest New Drugs; 1992 Jul; 10(2):103-6. PubMed ID: 1386842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study.
    Eisenhauer EA; Pritchard KI; Perrault DJ; Verma S; Pater JL
    Invest New Drugs; 1990 Aug; 8(3):283-7. PubMed ID: 2148741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of menogaril as initial chemotherapy for metastatic breast cancer.
    Kennedy MJ; Donehower RC; Grochow LB; Ettinger DS; Fetting JH; Abeloff MD
    Invest New Drugs; 1990 Aug; 8(3):289-94. PubMed ID: 2148742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II study of menogaril (NSC-269148) in colorectal carcinoma. A Southwest Oncology Group study.
    Whitehead RP; Earhart RH; Fleming T; Goodman P; Macdonald JS; Pollock T; Ungerleider JS
    Invest New Drugs; 1990 Aug; 8(3):295-7. PubMed ID: 2148743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menogaril in the treatment of relapsed multiple myeloma. A phase II trial of the Cancer Center of Wake Forest University.
    Cruz JM; Case LD; Dalton HB; Ramseur WL; Richards F; Jackson DV; Muss HB; Zekan PJ; Brodkin RA; Brown RC
    Invest New Drugs; 1992 Apr; 10(1):35-7. PubMed ID: 1535064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung.
    Joss RA; Monfardini S; Hansen M; Dombernowsky P; Renard J; Pinedo HM
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):263-5. PubMed ID: 2833403
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study.
    Brown TD; Goodman PJ; Fleming TR; Baker LH; Macdonald JS
    Invest New Drugs; 1991 Feb; 9(1):77-8. PubMed ID: 1827433
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase II evaluation of menogaril in patients with advanced cervical carcinoma. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic.
    LONG HJ; Wieand HS; Foley JF; Niedringhaus RD; Laurie JA; Morton RF; Goldberg RM; Mailliard JA; Malkasian GD; Edmonson JH
    Invest New Drugs; 1991 Nov; 9(4):349-51. PubMed ID: 1839536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction.
    Egorin MJ; Conley BA; Forrest A; Zuhowski EG; Sinibaldi V; Van Echo DA
    Cancer Res; 1987 Nov; 47(22):6104-10. PubMed ID: 2959359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial.
    Gundersen S; Monfardini S; Renard G; Van Glabbeke M; Pinedo H
    Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1707-8. PubMed ID: 2962875
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
    Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C
    Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053
    [No Abstract]   [Full Text] [Related]  

  • 33. A phase II study of menogaril in low-grade non-Hodgkin's lymphoma. An NCI Canada Clinical Trials Group study.
    Skillings J; Cripps C; Eisenhauer E; Pater J; Verma S; Walde D
    Invest New Drugs; 1991 Feb; 9(1):79-82. PubMed ID: 1827434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of menogarol in the treatment of advanced adenocarcinoma of the pancreas.
    Sternberg CN; Magill GB; Cheng EW; Hollander P
    Am J Clin Oncol; 1988 Apr; 11(2):174-6. PubMed ID: 2965856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase I clinical and pharmacokinetic study of the oral and the oral/intravenous administration of menogaril.
    Weiss GR; Brown TD; Kuhn JG; Von Hoff DD; Earhart RH; Adams WJ; Brewer JE; Hosley JD; Kasunic DA
    Invest New Drugs; 1993 Feb; 11(1):17-27. PubMed ID: 8349432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance of full dose menogaril (NSC 269148) in patients with abnormal hepatic and renal function.
    Conley BA; Egorin MJ; Sinibaldi V; Van Echo DA
    Invest New Drugs; 1990 Nov; 8(4):365-7. PubMed ID: 2150671
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase II study of i.v. menogaril in patients with malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group Study.
    McCulloch PB; Eisenhauer EA; Shibata HR; Young VP
    Cancer Treat Rep; 1987; 71(7-8):771-2. PubMed ID: 2955887
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase II study of weekly intravenous menogaril in the treatment of recurrent astrocytomas in adults.
    Stewart DJ; Hugenholtz H; DaSilva VF; Benoit BG; Richard MT; Verma S; Earhart R; Robillard L
    J Neurooncol; 1992 Jun; 13(2):183-8. PubMed ID: 1331346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menogaril: a new anthracycline agent entering clinical trials.
    McGovren JP; Nelson KG; Lassus M; Cradock JC; Plowman J; Christopher JP
    Invest New Drugs; 1984; 2(4):359-67. PubMed ID: 6239835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetic studies of menogaril (TUT-7) with rats].
    Ohashi K; Hara H; Takahashi F; Aso R; Akimoto T; Nakama K
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1825-9. PubMed ID: 1387773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.